Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
Zhaowu Ma, Xiaoqiang Xiang, Shiya Li, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 379-390
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Metabolic reprogramming in macrophage responses
Yang Liu, Ruyi Xu, Huiyao Gu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 355
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 151
Hypoxia: The Cornerstone of Glioblastoma
Marta Domènech, Ainhoa Hernández, Andrea Plaja, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12608-12608
Open Access | Times Cited: 116
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Yongchao Zhao, Weidong Xiong, Chaofu Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 89
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment
Shilin Wang, Guohong Liu, Yirong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 83
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 79
Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain
Bich Phuong Bui, Phuong Linh Nguyen, Kyeong Lee, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6054-6054
Open Access | Times Cited: 77
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
Ting‐Wan Kao, Geng-Hao Bai, Tian‐Li Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 45
Extracellular vesicles: The future of therapeutics and drug delivery systems
Md. Jamir Uddin, Popat Mohite, Shubham Munde, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 3, pp. 312-328
Open Access | Times Cited: 16
Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer
Jiayi Zhang, Mengqin Yao, Siyu Xia, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 2
The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy
Juan Li, Guo Zhang, Chenguang Liu, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 87-104
Open Access | Times Cited: 77
How far have we explored fungi to fight cancer?
Chee Wun How, Yong Sze Ong, Sze Shin Low, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 976-989
Closed Access | Times Cited: 61
Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis
Hardeep Singh Tuli, Jagjit Kaur, Kanupriya Vashishth, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 1, pp. 103-120
Closed Access | Times Cited: 55
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
Leah Davis, Matthias Recktenwald, Evan Hutt, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1259-1259
Open Access | Times Cited: 49
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection
Hardeep Singh Tuli, Vivek Kumar Garg, Sakshi Bhushan, et al.
Translational Oncology (2022) Vol. 27, pp. 101596-101596
Open Access | Times Cited: 46
HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression
Danfei Liu, Xiangyuan Luo, Meng Xie, et al.
Cancer Science (2022) Vol. 113, Iss. 10, pp. 3347-3361
Open Access | Times Cited: 40
Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1
Ying Liu, Hanwen Zhang, Yiwei Liu, et al.
Autophagy (2023) Vol. 19, Iss. 9, pp. 2443-2463
Open Access | Times Cited: 33
Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal
Suneel Kumar, Stephen O. Mathew, Ravindra Prasad Aharwal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 160-160
Open Access | Times Cited: 32
Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Yi Pan, Longcai Liu, Xiaozhou Mou, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 20875-20924
Closed Access | Times Cited: 26
NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
Peng Zhang, Liang Chen, Fenfang Zhou, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 25
Cancer treatment: Role of natural products. Time to have a serious rethink
Shrikant B. Mali
Oral Oncology Reports (2023) Vol. 6, pp. 100040-100040
Open Access | Times Cited: 25
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
Jung Ho Han, Eun‐Ji Lee, Mi-Ju Park, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Interplay of dietary antioxidants and gut microbiome in human health: What has been learnt thus far?
Nikunj Naliyadhara, Aviral Kumar, Shailendra Kumar Gangwar, et al.
Journal of Functional Foods (2022) Vol. 100, pp. 105365-105365
Open Access | Times Cited: 34
Lactate promotes metastasis of normoxic colorectal cancer stem cells through PGC-1α-mediated oxidative phosphorylation
Shuang Liu, Hui Zhao, Yibing Hu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top